Brief: Lucid Diagnostics Receives Notice Of Allowance For Key Patent Underlying Its Esoguard Esophageal DNA Test

Lucid Diagnostics

15/10/2024 13:06

Oct 15 (Reuters) - Lucid Diagnostics Inc  LUCD.O :
    * LUCID DIAGNOSTICS RECEIVES NOTICE OF ALLOWANCE FOR KEY
PATENT
UNDERLYING ITS ESOGUARD ESOPHAGEAL DNA TEST

Source text for Eikon:  ID:nPn3vgZZPa 
Further company coverage:  LUCD.O 

 ((Reuters.Briefs@thomsonreuters.com;))